Copyright
©The Author(s) 2022.
World J Diabetes. Dec 15, 2022; 13(12): 1154-1167
Published online Dec 15, 2022. doi: 10.4239/wjd.v13.i12.1154
Published online Dec 15, 2022. doi: 10.4239/wjd.v13.i12.1154
OR | 95%CI | P value | ||
Model 1 | Sex (female vs male) | 1.88 | 0.70-5.05 | 0.21 |
Baseline characteristics | Age (yr) | 0.98 | 0.93-1.02 | 0.34 |
R-square: 2.8% | BMI (kg/m2) | 0.95 | 0.88-1.04 | 0.27 |
Model 2 | Sex (female vs male) | 7.23 | 1.57-33.23 | 0.011 |
Baseline characteristics | Age (yr) | 1.00 | 0.92-1.09 | 0.97 |
R-square: 54.0% | BMI (kg/m2) | 0.94 | 0.84-1.05 | 0.26 |
HbA1c (%) | 1.19 | 0.88-1.60 | 0.25 | |
Baseline eGFR (mL/min/1.73 m2 of body surface area) | 1.05 | 1.01-1.08 | 0.013 | |
NLRmax | 1.36 | 1.21-1.54 | < 0.001 | |
Model 3 | Sex (female vs male) | 7.26 | 1.58-33.44 | 0.011 |
Baseline characteristics | BMI (kg/m2) | 0.94 | 0.84-1.05 | 0.26 |
R-square: 54.0% | Age (yr) | 1.00 | 0.92-1.09 | 0.98 |
HbA1c (%) | 1.19 | 0.87-1.61 | 0.28 | |
Baseline eGFR (mL/min/1.73 m2 of body surface area) | 1.05 | 1.01-1.08 | 0.012 | |
NLRmax | 1.37 | 1.21-1.55 | < 0.001 | |
Albuminuria | 1.12 | 0.32-3.96 | 0.86 |
- Citation: Bashkin A, Shehadeh M, Shbita L, Namoura K, Haiek R, Kuyantseva E, Boulos Y, Yakir O, Kruzel-Davila E. Baseline moderate-range albuminuria is associated with protection against severe COVID-19 pneumonia. World J Diabetes 2022; 13(12): 1154-1167
- URL: https://www.wjgnet.com/1948-9358/full/v13/i12/1154.htm
- DOI: https://dx.doi.org/10.4239/wjd.v13.i12.1154